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Metabotropic glutamate subtype 1 (mGlu1) receptor is thought to play a role in synaptic responses in
thalamic relay nuclei. The aim of this study was to evaluate the positive allosteric modulator (PAM) Ro67-
4853 as a tool to modulate thalamic mGlu1 receptors on single thalamic neurones in vivo. Ro67-4853,
applied by iontophoresis onto ventrobasal thalamus neurones of urethane-anaesthetised rats, selectively
enhanced responses to the agonist (S)-3,5-dihydroxy-phenylglycine (DHPG), an effect consistent with
mGlu1 potentiation. The PAM was also able to enhance maintained responses to 10 Hz trains of sensory
stimulation of the vibrissae, but had little effect on responses to single sensory stimuli. Thus Ro67-4853
appears to be a highly selective tool that can be useful in investigating how mGlu1 receptor potentiation
can alter neural processing in vivo. Our results show the importance of mGlu1 in sensory processing and
attentionmechanisms at the thalamic level and suggest that positive modulation of mGlu1 receptors might
be a useful mechanism for enhancing cognitive and attentional processes.
 2011 Elsevier Ltd. All rights reserved.1. Introduction
It is now well-established that metabotropic glutamate (mGlu)
receptors participate in synaptic transmission and modulation
throughout the central nervous system (Niswender and Conn, 2010).
The eight knownmGlu receptors can be placed into three groups on
the basis of sequence homology, pharmacology and intracellular
transduction mechanisms (Nakanishi, 1992; Niswender and Conn,
2010). The Group I (mGlu1 and mGlu5) receptors have a predomi-
nantly post-synaptic location where they can couple to inositol
phosphate metabolism and enhance post-synaptic excitability via
changes in Kþ conductances and/or modulation of ionotropic
glutamate receptors such as the N-methyl-D-aspartate (NMDA)
receptor. Both mGlu1 and mGlu5 receptors are activated by the
agonist (S)-3,5-dihydroxy-phenylglycine (DHPG) (Schoepp et al.,
1994; Schoepp et al., 1999), thus making the selective activation of
either of these receptors difﬁcult. However, positive allosteric
modulators (PAMs) that are selective for eithermGlu1ormGlu5have
more recently been developed and characterised (Niswender and
Conn, 2010; Nicoletti et al., 2011). For example Ro67-4853 has
been shown to potentiate mGlu1 receptor responses in a number of
in vitro systems (Knoﬂach et al., 2001). Thus such a compoundwould
be ideally suited to potentiate synaptic responses that have and.
All rights reserved.mGlu1 involvement whist having little direct effect in the absence of
physiological stimulation of the receptor. This would therefore be
a more selective and speciﬁc way of enhancing or activating mGlu1
receptors in a neural circuit thanby the applicationof an agonist such
as DHPG. Furthermore, Ro67-4853 might be expected to reveal
speciﬁc mGlu1-mediated effects on neural circuit function in a situ-
ationwhere these receptors are located in distinct synaptic locations.
Previous work from this laboratory has shown that mGlu1 and
mGlu5 receptor activation depolarises and excites thalamic relay
cells and contributes to thalamic synaptic responses in vivo and
in vitro (Salt and Turner, 1998; Salt and Binns, 2000; Turner and
Salt, 2000). In particular, working in various thalamic relay nuclei,
we and others have shown using selective antagonists that mGlu1
receptors are associated with the corticofugal input onto thalamic
relay cells (Turner and Salt, 2000; Rivadulla et al., 2002; Reichova
and Sherman, 2004). This is consistent with neuroanatomical
data that reveals mGlu1 receptor localisation on the dendrites of
thalamic relay cells beneath or close to terminals that appear to be
of cortical origin (Martin et al., 1992; Godwin et al., 1996;
Vidnyanszky et al., 1996). Thus a selective potentiator of mGlu1
receptors could be a useful experimental tool to identify mGlu1
receptor function. Furthermore, such an agent might be useful as
selective potentiator of activity either experimentally or thera-
peutically in neural pathways that utilise mGlu1.
The aim of this study was ﬁrstly to evaluate the potential of the
positive allosteric modulator (PAM) of mGlu1, Ro67-4853 (Knoﬂach
et al., 2001), to modulate mGlu1 responses in vivo in the thalamus
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Ro67-4853 could affect the responses of thalamic relay cells to
sensory stimuli of different types to see whether mGlu1 receptors
are recruited into synaptic responses under different stimulus
conditions. This is important in the understanding of the contri-
bution of cortico-thalamic modulatory input to sensory responses
and in terms of understanding how mGlu1-receptor PAMs might
affect sensory processing. In order to achieve these aims we have
carried out single neurone recordings and iontophoretic applica-
tion of glutamatergic agents in the rat ventrobasal thalamus in vivo.
The results of this study show that Ro67-4853 can potentiate
mGlu1-receptor-mediated responses to the agonist DHPG, and that
this appears to be a selective effect. Furthermore, Ro67-4853 was
found to potentiate responses of ventrobasal thalamus neurones to
somatosensory stimulation in a stimulus-speciﬁc manner, consis-
tent with a role for mGlu1 receptors in sensory processing in the
thalamus.2. Methods
Experiments were carried out as detailed previously in male adult Wistar rats
(270e400 g) anaesthetised with urethane (1.2 g/kg, I.P.) (Salt, 1987; Salt and Binns,
2000). All procedures were approved by the Home Ofﬁce (UK) and were in accor-
dance with the Animals (Scientiﬁc Procedures) Act 1986. Electroencephalogram and
electrocardiogram were recorded throughout and anaesthesia was maintained by
additional I.P. administration of urethane as required. Single neurone recordings
were made from ventrobasal thalamus neurones using the centre barrel (ﬁlled with
4 M NaCl) of seven-barrel glass electrodes, and substances under investigation were
applied in the recording location from the six outer barrels of the electrode using the
iontophoretic technique with a Neurophore BH2 system. Each of the outer barrels
contained a selection from one of the following substances: NMDA (50 mM, pH 8.0
in 150 mM NaCl), LY367385 (100 mM in water, pH 8.0), DHPG (50 mM in 150 mM
NaCl, pH 3.5), Ro67-4853 (2 mM in 10% DMSO in 150 mM NaCl, pH 7.5), Vehicle
control (10%DMSO in 150 mM NaCl, pH 7.5), Pontamine Sky Blue dye (2% in 1 M
NaCl), 1 M NaCl. DHPG was ejected as a cation, all other substances were ejected as
anions. Agents were prevented from diffusing from the iontophoresis barrel by
applying a retaining current (5e15 nA) of opposite polarity to the ejection current.
Automatic current balancing was routinely performed through the 1 M NaCl barrel,R090114e
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Fig. 1. Selective potentiation of DHPG responses by Ro67-4853. AeC: Records are counts
application of either DHPG or NMDA, as indicated by the marker bars above the records. A
commenced 150 s previously). C e Recovery (washout) from the Ro67-4853 effect. Record co
or Vehicle on agonist responses. Bars represent mean % change from control (100%) of respon
agonist responses after termination of the PAM or Vehicle application. D e Ro67-4853 prod
responses. Data from 15 neurones. E e Passing iontophoretic current through Vehicle-contai
neurones that were also tested with Ro67-4853 and included in A. ***P < 0.001; ns not sigalthough this was also switched off in a small number of experiments in order to
verify that results were similar under both types of iontophoretic procedure.
Two types of experimental protocol were followed. Firstly, in order to evaluate
the effectiveness and speciﬁcity of Ro67-4853 when applied via iontophoresis, the
agonists DHPG and NMDA were applied alternately at regular intervals (typically
180 s) in order to evoke consistent sub-maximal increases in action potential ﬁring
rate, as described previously (Salt and Binns, 2000). When stable responses to the
agonists were achieved, Ro67-4853 was co-applied (typically for 3e9 min) and
changes in the responses to the agonists were noted. Application of Ro67-4853 was
then terminated and responses to agonists continued to be recorded. Secondly, in
order to evaluate the effect of the PAM on sensory input, deﬂection of facial vibrissae
was performed using an electronically-gated air jet (10e20 ms duration) directed at
a single vibrissa (Salt, 1987). Such stimuli were presented alternately as single
stimuli and in trains of stimuli (10 Hz,1 s duration), separated by 4e5 s. When stable
responses to vibrissa deﬂectionwere achieved, Ro67-4853 was co-applied (typically
for 3e9 min) and changes in the responses to sensory stimulation were noted. This
enabled a direct comparison of the effects of R067-4853 on the two modes of
sensory stimulation. Application of Ro67-4853 was then terminated and responses
to sensory stimulation continued to be recorded.
Action potential signals were ampliﬁed using an Axoprobe 1A ampliﬁer, gated,
timed and recorded via a CED1401 interface hosted on a computer running Spike2
software (Cambridge Electronic Design, UK). Data were analysed by plotting peri-
stimulus time histograms (PSTHs) from these recordings and counting the spikes
evoked by either sensory stimulation or agonist ejection. Responsemagnitudes were
calculated by counting action potential spikes evoked by each agonist or sensory
stimulus under control conditions, during application of the PAM, and after the end
of the PAM application during the washout (recovery) phase. Responses in the
presence of PAM were routinely expressed as a percentage of the pre-PAM ejection
control response. Non-parametric statistics (KruskaleWallis test and Wilcoxon
matched-pairs test) were used to test for signiﬁcant differences between control and
PAM conditions.3. Results
3.1. Effects of Ro67-4853 on responses of thalamic neurones to
iontophoretically applied DHPG and NMDA
In agreement with our previous ﬁndings, VB neurones under our
experimental conditions were almost quiescent, and iontophoretic
applicationsofDHPGorNMDAproduced increases inactionpotential
ﬁring of thalamic neurones (see Fig. 1A) as reported previously bys (n =15)NMDA DHPG
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was co-applied (100e200 nA, mean ¼ 115  11 nA), the PAM
enhanced responses toDHPGwith relatively little effect on responses
to NMDA (Fig. 1B). Ro67-4853 was applied to 15 neurones that were
excited by alternate applications of DHPG and NMDA, and overall
a selective enhancement of DHPG responses to 275% (35%,
P < 0.001) of control values was seen whereas responses to NMDA
were not signiﬁcantly different to control (12411%) (Fig.1D). In 5 of
these neurones a vehicle control was also performedwhere the same
iontophoretic current was passed through a barrel containing the
vehicle used for Ro67-4853: in these cases no signiﬁcant overall
potentiation of either agonist was seen (Fig. 1E). In order to exclude
the possibility that there was some interaction between NMDA and
DHPG responses a further 9 neurones were recorded where DHPG
was regularly ejected without alternating NMDA applications, and in
these experiments application of Ro67-4853 was found to have the
same potentiating effect on DHPG responses as before (246 44% of
control, n ¼ 9, P < 0.005).3.2. Effects of Ro67-4853 on responses of thalamic neurones to
somatosensory stimuli
Vibrissal stimulation delivered as single deﬂections (10e20 ms)
typically produced responses of one to three action potentials at
a latency of 12e30 ms, as described previously (Salt, 1987). When
stimuli were presented in 10 Hz trains, the responses to the ﬁrst
stimulus in the trainwere similar to those seen in response to single
stimuli, but the responses to subsequent stimuli in the train were
usually reduced (Fig. 2B). Iontophoretic application of Ro67-4853
did not signiﬁcantly alter the responses to single stimuli
(102%  3% of control, n ¼ 18), but it did potentiate responses to
trains of stimuli, as shown in the example in Fig. 2 and summarised
in Fig. 3A and B. Overall, responses of 20 neurones to trains of
stimuli were enhanced to 125% (6%) of control responsesControl Ro67-4853, 60s
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Fig. 2. Potentiation of sensory responses of VB thalamus neurones by Ro67-4853. Raster di
trials of either a single stimulus (A) or train of stimuli (B) to a vibrissa, presented at the ti
responses to single stimuli (arrow). Note also that following the initial action potential sp
GABAergic inhibition arising from the thalamic reticular nucleus. B e Ro67-4853 potenti
component.(P < 0.001) (Fig. 3B). Furthermore, analysis of the responses to
trains of deﬂections revealed that latter components of the train
response (response to last nine stimuli in the train) were potenti-
ated by the PAM (131%  7%, P < 0.001), whereas the initial
component (response to the ﬁrst stimulus of the train) remained
unaffected (99%  4% of control) (Fig. 3B).
In order to verify that the potentiations by Ro67-4853 of
responses to trains of vibrissa stimulation were indeed mediated
via mGlu1 receptors, we proceeded to eject a selective mGlu1
receptor antagonist, LY367385 (Clark et al., 1997; Salt and Binns,
2000), continuously (40 nA) on 8 of the 20 neurones after
recovery from the Ro67-4853 application. In agreement with our
previous ﬁndings (Salt and Turner, 1998), LY367385 had no signif-
icant effect on sensory responses. Subsequent application of
Ro67-4853 during the LY367385 ejection was without effect on the
maintained vibrissal responses to trains of stimuli (97%  12% of
control). Furthermore, after termination of the LY367385 ejection,
when the stimulation and Ro67-4853 application protocol was
repeated, Ro67-4853 was found to potentiate responses again
(136%  20% of control). These data are summarised in Fig. 3C.4. Discussion
The data reported here represent, to our knowledge, the ﬁrst
in vivo characterisation of Ro67-4853 at the single neurone level.
Our ﬁndings are in accord with previous in vitro work (Knoﬂach
et al., 2001), and show that Ro67-4853 can act as a selective posi-
tive modulator of mGlu1 receptor-mediated responses in the
thalamus in vivo. Furthermore, this property can be exploited to
selectively enhance mGlu1-mediated synaptic response
components.
Previous work from this laboratory has shown that VB thalamus
neurones can be excited by activation of Group I mGlu receptors.
Furthermore, we have shown that the post-synaptic excitationR100929c
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Fig. 3. Overall effect of Ro67-4853 on responses to single stimuli or trains of stimuli directed at vibrissae. Bars represent mean % change from control (100%) of responses to vibrissa
stimulation during application of the PAM and recovery of responses after termination of the PAM application. A e Responses of 18 neurones to single stimuli were not affected by
the PAM. B e Responses of 20 neurones to trains of vibrissa stimulation were potentiated by PAM application. When responses were segregated into the initial response component
(to the ﬁrst stimulus in the train) and the remaining maintained response component, it was the latter that was potentiated by the PAM. C e Responses of 8 of the neurones shown
in B showing the effect of PAM application on maintained sensory responses under control conditions, and during co-application of the mGlu1 antagonist LY367385 (box). Note that
LY367385 prevented the potentiation of responses by the PAM. ***P < 0.001; **P < 0.01; *P < 0.05; ns not signiﬁcant.
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the mGlu1 receptor subtype rather than the mGlu5 subtype (Salt
et al., 1999; Salt and Binns, 2000). This is consistent with the high
levels of expression of this receptor on neurones in this part of the
brain (Martin et al., 1992; Shigemoto et al., 1992; Neto et al., 2000;
Ngomba et al., 2011a). In the present study, we have shown that
Ro67-4853 can potentiate responses to DHPG whilst having rela-
tively little overall effect on responses to NMDA. This indicates that
positive allosteric modulation of mGlu1 receptors can be achieved
using Ro67-4853 in vivo. It is noteworthy that we have previously
found that NMDA receptor responses can be potentiated by acti-
vation of mGlu1 receptors using DHPG in vivo (Salt and Binns,
2000). Our present ﬁnding that NMDA responses were not
affected by Ro67-4853 application would suggest that there is little
tonic activation of mGlu1 receptors under our experimental
conditions.
In the present study we also investigated the effects of the
mGlu1 PAM on responses of VB neurones to vibrissa stimulation.
Our previous work has found that vibrissal responses are mediated
by ionotropic glutamate receptors of both the non-NMDA and
NMDA type (Salt, 1987; Salt and Eaton, 1991) with little apparent
involvement of mGlu receptors, as indicated by the lack of effect of
various competitive mGlu receptor antagonists (Eaton et al., 1993;
Salt and Eaton, 1994), including the mGlu1-selective antagonist
LY367385 (Salt and Turner, 1998). Interestingly, we found that
Ro67-4853 could nevertheless enhance components of vibrissal
responses under certain conditions: in particular we found that
responses to repetitive vibrissa stimulation were enhanced by the
PAM whereas responses single stimuli or to the initial componentof a repetitive stimulus were unaffected. This, together with the
lack of effect of mGlu antagonists on sensory responses (see above),
suggests that an mGlu1-receptor component is present but sub-
threshold under our experimental conditions, and that this can
be selectively enhanced by the PAM. There is considerable
anatomical and physiological evidence showing that mGlu1
receptors are post-synaptic to corticofugal afferents terminating on
the dendrites of thalamic relay cells but are not post-synaptic to
sensory afferent terminals (Martin et al., 1992; Godwin et al., 1996;
Vidnyanszky et al., 1996; Guillery and Sherman, 2002). This,
together with our current ﬁndings with Ro67-4853, suggests that
application of the PAM results in a selective enhancement of the
cortical input to VB cells in a stimulus-speciﬁc manner. Further-
more, the ﬁnding that the PAM enhances the latter components of
sensory responses is consistent with such a view, as it might be
expected that a facilitatory cortical feedback operating via
a synaptic mGlu receptor would show a requirement for repeated
activation and a relatively slow time course.
It has been suggested that the modulatory cortico-thalamic
pathways that project from Layer 6 of the cortex to the thalamic
relay nuclei may play an important role in governing sensory
processing in the thalamus and attentional mechanisms (Guillery
and Sherman, 2002; Sherman and Guillery, 2002). Our ﬁnding
that it is possible to enhance presumed cortico-thalamic inputs to
the thalamus with Ro67-4853 has important implications in this
sphere. Firstly, our results indicate that it is possible to pharma-
cologically enhance the cortico-thalamic contribution to sensory
processing in a speciﬁc manner so as to enhance thalamic sensory
responses. This will in turn be fed to the cortex and result in
T.E. Salt et al. / Neuropharmacology 62 (2012) 1695e1699 1699increased cortical responses that will in turn be projected back
down to the thalamus. Secondly, our results indicate that drugs that
have mGlu1 receptor PAM activity could be a powerful means of
modulating central sensory processing and they could have
a function as cognitive enhancers. In this respect it is also of interest
to note that a different mGlu1 PAM has been recently shown to
affect spike-and-wave discharges in a genetic model of absence
epilepsy, an effect that could be due to modulation of cortico-
thalamic feedback projections (Ngomba et al., 2011a,b).
In conclusion, we have shown that Ro67-4853 appears to be
a highly selective tool that should be useful in investigating how
mGlu1 receptor potentiation can alter neural processing in vivo.
This will be important in terms of developing a proof of concept
that mGlu1 receptor modulation could provide useful central
nervous system effects. Furthermore, our results underline the
importance of mGlu1 in sensory processing and attention mecha-
nisms at the thalamic level and suggest that positive modulation of
mGlu1 receptors might be a useful mechanism for enhancing
cognitive and attentional processes.Acknowledgements
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